Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Q32 Bio Inc. before investing.

In this article, we go over a few key elements for understanding Q32 Bio Inc.’s stock price such as:

• Q32 Bio Inc.’s current stock price and volume
• Why Q32 Bio Inc.’s stock price changed recently
• Upgrades and downgrades for QTTB from analysts
• QTTB’s stock price momentum as measured by its relative strength

About Q32 Bio Inc. (QTTB)

Before we jump into Q32 Bio Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb – CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

Want to learn more about Q32 Bio Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Q32 Bio Inc..

Q32 Bio Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Q32 Bio Inc.’s stock price was $15.680.

Q32 Bio Inc. is up 0.77% from its previous closing price of $15.560.

During the last market session, Q32 Bio Inc.’s stock traded between $15.000 and $15.990. Currently, there are approximately 14.10 million shares outstanding for Q32 Bio Inc..

Q32 Bio Inc.’s price-earnings (P/E) ratio is currently at 6.0, which is low compared to the Biotechnology industry median of 19. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Q32 Bio Inc. Stock Price History

Q32 Bio Inc.’s (QTTB) price is currently up 23.08% so far this month.

During the month of July, Q32 Bio Inc.’s stock price has reached a high of $23.570 and a low of $10.815.

Over the last year, Q32 Bio Inc. has hit prices as high as $23.570 and as low as $1.569. Year to date, Q32 Bio Inc.’s stock is up 372.29%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Q32 Bio Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Q32 Bio Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Q32 Bio Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Q32 Bio Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Q32 Bio Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Q32 Bio Inc. (QTTB) by visiting AAII Stock Evaluator.

Relative Price Strength of Q32 Bio Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Q32 Bio Inc. has a weighted four-quarter relative price strength of 95.99%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Q32 Bio Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Q32 Bio Inc. Stock Price: Bottom Line

As of July 31, 2026, Q32 Bio Inc.’s stock price is $15.680, which is up 0.77% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Q32 Bio Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.